Table of Contents
1. Executive Summary
2. Market Background and Classifications
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2014 to 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global MicroRNA (miRNA) Market Trends and Forecast
3.3: Global MicroRNA (miRNA) Market by Research Tool
3.3.1: Services
3.3.1.1: Sample collection
3.3.1.1.1: Whole Blood
3.3.1.1.2: Serum
3.3.1.1.3: Plasma
3.3.1.2: miRNA cDNA Synthesis
3.3.1.3: Profiling & Purification
3.3.1.4: Detection
3.3.1.5: Functional Studies
3.3.1.5.1: NGS
3.3.1.5.2: Microarray
3.3.1.5.3: Real Time PCR
3.3.1.5.4: Others
3.3.2: Products
3.3.2.1: Instruments
3.3.2.2: Consumables
3.3.2.2.1: Isolation & Purification
3.3.2.2.2: Quantification & Detection
3.3.2.2.3: Functional Analysis
3.3.2.2.4: Others
3.4: Global MicroRNA (miRNA) Market by Application
3.4.1: Cancer
3.4.2: Infectious Dieseasess
3.4.3: Immunological Disorders
3.4.4: Cardiovascular Dieseases
3.4.5: Neurological Dieseases
3.4.6: Others
3.5: Global MicroRNA (miRNA) Market by End User
3.5.1: Biotechnology and Pharmaceutical Companies
3.5.2: Academic & Government Research Institutes
3.5.3: Others
4. Market Trends and Forecast Analysis by Region
4.1: Global MicroRNA (miRNA) Market by Region
4.2: North American MicroRNA (miRNA) Market
4.2.1: Market by Research Tool: Services (Sample Collection (Whole Blood, Serum, And Plasma), Mirna Cdna Synthesis, Profiling & Purification, Detection, and Functional Studies (NGS, Microarray, Real Time PCR, and Others), and Products (Instruments and Consumables (Isolation & Purification, Quantification & Detection, Functional Analysis, and Others)
4.2.2: Market by Application: Cancer, Infectious Dieseasess, Immunological Disorders, Cardiovascular Dieseases, Neurological Dieseases, and Others
4.2.3: Market by End User: Biotechnology and Pharmaceutical Companies, Academic & Government Research Institutes, and Others
4.2.4: The United States MicroRNA (miRNA) Market
4.2.5: The Canadian MicroRNA (miRNA) Market
4.2.6: The Mexican MicroRNA (miRNA) Market
4.3: European MicroRNA (miRNA) Market
4.3.1: Market by Research Tool: Services (Sample Collection (Whole Blood, Serum, And Plasma), Mirna Cdna Synthesis, Profiling & Purification, Detection, and Functional Studies (NGS, Microarray, Real Time PCR, and Others), and Products (Instruments and Consumables (Isolation & Purification, Quantification & Detection, Functional Analysis, and Others)
4.3.2: Market by Application: Cancer, Infectious Dieseasess, Immunological Disorders, Cardiovascular Dieseases, Neurological Dieseases, and Others
4.3.3: Market by End User: Biotechnology and Pharmaceutical Companies, Academic & Government Research Institutes, and Others
4.3.4: The United Kingdom MicroRNA (miRNA) Market
4.3.5: The Spanish MicroRNA (miRNA) Market
4.3.6: The German MicroRNA (miRNA) Market
4.3.7: The French MicroRNA (miRNA) Market
4.4: APAC MicroRNA (miRNA) Market
4.4.1: Market by Research Tool: Services (Sample Collection (Whole Blood, Serum, And Plasma), Mirna Cdna Synthesis, Profiling & Purification, Detection, and Functional Studies (NGS, Microarray, Real Time PCR, and Others), and Products (Instruments and Consumables (Isolation & Purification, Quantification & Detection, Functional Analysis, and Others)
4.4.2: Market by Application: Cancer, Infectious Dieseasess, Immunological Disorders, Cardiovascular Dieseases, Neurological Dieseases, and Others
4.4.3: Market by End User: Biotechnology and Pharmaceutical Companies, Academic & Government Research Institutes, and Others
4.4.4: The Chinese MicroRNA (miRNA) Market
4.4.5: The Indian MicroRNA (miRNA) Market
4.4.6: The Japanese MicroRNA (miRNA) Market
4.5: ROW MicroRNA (miRNA) Market
4.5.1: Market by Research Tool: Services (Sample Collection (Whole Blood, Serum, And Plasma), Mirna Cdna Synthesis, Profiling & Purification, Detection, and Functional Studies (NGS, Microarray, Real Time PCR, and Others), and Products (Instruments and Consumables (Isolation & Purification, Quantification & Detection, Functional Analysis, and Others)
4.5.2: Market by Application: Cancer, Infectious Dieseasess, Immunological Disorders, Cardiovascular Dieseases, Neurological Dieseases, and Others
4.5.3: Market by End User: Biotechnology and Pharmaceutical Companies, Academic & Government Research Institutes, and Others
4.5.4: Brazilian MicroRNA (miRNA) Market
5. Competitor Analysis
5.1: Market Share Analysis
5.2: Product Portfolio Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. Cost Structure Analysis
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. Growth Opportunities and Strategic Analysis
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global MicroRNA (miRNA) Market by Research Tool
7.1.2: Growth Opportunities for the Global MicroRNA (miRNA) Market by Application
7.1.3: Growth Opportunities for the Global MicroRNA (miRNA) Market by End User
7.1.4: Growth Opportunities for the Global MicroRNA (miRNA) Market by Region
7.2: Emerging Trends in the Global MicroRNA (miRNA) Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global MicroRNA (miRNA) Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global MicroRNA (miRNA) Market
7.3.4: Certification and Licensing
8. Company Profiles of Leading Players
8.1: Thermofisher Scientific
8.2: Agilent Technologies
8.3: Merck
8.4: QIAGEN
8.5: NanoString Technologies
8.6: Company 6
8.7: Company 7
8.8: Company 8
8.9: Company 9
8.10: Company 10